xolair - search results
If you're not happy with the results, please do another search
This week, the FDA approved Xolair for the treatment of food allergies. Here's a slideshow featuring six important facts to know about this new...
A significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placebo.
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure.
Small study finds drug may be effective in treating IA.
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Assessment for both single agent and add-on therapy.
Shows promise for the treatment of chronic spontaneous urticaria, food allergies, asthma and eczema.
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.
Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour of food...
12Page 1 of 2